1. Home
  2. BDAI vs HBIO Comparison

BDAI vs HBIO Comparison

Compare BDAI & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BDAI

Biddance AI Systems Inc. Class A Ordinary Share

N/A

Current Price

$1.93

Market Cap

22.7M

Sector

Technology

ML Signal

N/A

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

N/A

Current Price

$9.78

Market Cap

26.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BDAI
HBIO
Founded
1996
1901
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.7M
26.5M
IPO Year
2018
2000

Fundamental Metrics

Financial Performance
Metric
BDAI
HBIO
Price
$1.93
$9.78
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $10.25
AVG Volume (30 Days)
★ 47.1K
21.7K
Earning Date
10-23-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $116,176,000.00
Revenue This Year
N/A
$3.79
Revenue Next Year
N/A
$5.54
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.70
$0.40
52 Week High
$2.77
$9.60

Technical Indicators

Market Signals
Indicator
BDAI
HBIO
Relative Strength Index (RSI) 41.78 73.59
Support Level $1.84 $5.91
Resistance Level $2.29 N/A
Average True Range (ATR) 0.34 0.48
MACD -0.03 0.09
Stochastic Oscillator 25.70 80.00

Price Performance

Historical Comparison
BDAI
HBIO

About BDAI Biddance AI Systems Inc. Class A Ordinary Share

Biddance AI Systems Inc, formerly Hitek Global Inc, is a provider of information technology consulting and solutions services. The company has two lines of business services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from Hardware and equipment sales, Tax services, and Software sales.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: